Chemed Stock - Long-term hospice and plumbing model under review

Chemed Corp balances its VITAS hospice arm and Roto-Rooter plumbing services in a dual-business model that shapes its long-term earnings profile. With no fresh filings today, investors are reassessing how this structure supports growth and resilience.

Edited by ad hoc news Long-Term & Business-Model Desk. Verified prior to publication on 06/20/2026, 06:17 PM ET. Details in the imprint.

Chemed Corp (US1638321034) runs a unusual combination of businesses in US hospice care and plumbing services that has attracted steady investor attention. With no new investor-relations filings or major analyst moves reported today, the focus shifts to the durability of this dual-model setup.

What recent data show

Chemed stock most recently closed around the mid-$430s per share, according to a late-week quote snapshot from a major financial data portal. This implies a market capitalization in the high single-digit billions of dollars based on the latest share count.

Consensus data from an earnings-calendar service indicate that Chemed typically reports quarterly figures in line with the broader US reporting cycle, with its next update expected in the coming months. Analysts generally frame the group as a defensive healthcare-and-services combination rather than a pure cyclical name.

How the long-term model works

The core of Chemed’s long-term story is the balance between its VITAS hospice business and the Roto-Rooter plumbing and drain services arm. VITAS provides end-of-life care under US Medicare and Medicaid programs, which can offer relatively stable reimbursement streams over time.

Roto-Rooter, by contrast, operates a network of company-owned branches, independent contractors and franchisees that offer plumbing, sewer and drain cleaning services to residential and commercial customers. That operation is more exposed to local economic conditions and housing dynamics, but it also brings pricing flexibility.

Why investors watch the mix

Over the years, investors have tended to view VITAS as the main earnings driver, given its scale and margin profile. The hospice segment benefits from demographic trends such as an aging US population and increased acceptance of hospice care as a standard part of the care continuum.

Roto-Rooter adds a different earnings cycle, sometimes cushioning hospice volatility and sometimes amplifying overall growth in expansion phases. The combination has historically delivered solid returns on capital, which many portfolio managers see as a key justification for Chemed’s valuation multiples.

What the company sells

Chemed makes most of its money through VITAS Healthcare, which delivers hospice care at home, in nursing facilities and in dedicated inpatient units, as well as through Roto-Rooter, which offers branded plumbing, sewer and drain cleaning services across North America.

Where the stock trades today

The shares of Chemed Corp (US1638321034) trade on the New York Stock Exchange around the mid-$430 range as of 06/18/2026, 05:27 PM ET.

Key facts on Chemed stock

• Company: Chemed Corp Inc.
• ISIN: US1638321034
• WKN: 859141
• Ticker: CHE
• Venue: NYSE
• Price (as of 06/18/2026, 05:27 PM ET): 436.83 USD
• Market cap: 7,000,000,000 USD (as of 06/18/2026)
• Sector / Industry: Health Care - Health Care Providers & Services
• Index membership: Standard & Poor's 400 index
• Next earnings date: not officially scheduled

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.